drugset / Trial / NCT06624904
Losartan and Social Processing
Phase 0
Recruiting
68 enrolled
University of Oxford
National Institute for Health Research, United Kingdom · collab
RandomizedParallel-groupTriple-blindBasic science
Summary
This study explores the effects of single-dose losartan (50mg) versus placebo on social processing in healthy volunteers.
Timeline
- Start
- 2024-08-19
- Primary completion
- 2025-10-01
- Completion
- 2025-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Losartan | Other / unclassified | 50 mg | — |